NCT03770637: A trial that was reported late by Xeris Pharmaceuticals
This trial has reported, although it was 284 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03770637 |
|---|---|
| Title | A Phase 2, Interventional, Randomized, Double-Blind, Placebo-Controlled Pilot Study of Glucagon RTU in Subjects Who Experience Hyperinsulinemic Hypoglycemia After Bariatric Surgery |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 10, 2019 |
| Completion date | Feb. 26, 2020 |
| Required reporting date | Feb. 25, 2021, midnight |
| Actual reporting date | Dec. 7, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 284 |